Log in

NASDAQ:LXRXLexicon Pharmaceuticals SEC Filings & 10K Form

$1.94
+0.09 (+4.86 %)
(As of 07/10/2020 04:00 PM ET)
Add
Compare
Today's Range
$1.86
Now: $1.94
$1.94
50-Day Range
$1.85
MA: $1.96
$2.19
52-Week Range
$1.13
Now: $1.94
$6.39
Volume611,000 shs
Average Volume798,208 shs
Market Capitalization$207.52 million
P/E Ratio3.13
Dividend YieldN/A
Beta1.16

SEC Filings

Lexicon Pharmaceuticals (NASDAQ:LXRX) SEC Filings

DateFilerForm TypeView
05/29/2020
3:33 PM
Lexicon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/27/2020
3:49 PM
Lexicon Pharmaceuticals (Issuer)
Swain Judith L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2020
3:48 PM
Lexicon Pharmaceuticals (Issuer)
SOBECKI CHRISTOPHER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2020
6:04 AM
Lexicon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2020
4:24 PM
Lexicon Pharmaceuticals (Issuer)
WADE JEFFREY L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2020
3:57 PM
Lexicon Pharmaceuticals (Filer)
Form DEFA14A
03/13/2020
6:10 AM
Lexicon Pharmaceuticals (Filer)
Form DEFA14A
03/13/2020
6:07 AM
Lexicon Pharmaceuticals (Filer)
Form DEF 14A
03/12/2020
4:26 PM
Lexicon Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/12/2020
6:04 AM
Lexicon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/10/2020
3:18 PM
Lexicon Pharmaceuticals (Issuer)
WADE JEFFREY L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2020
3:15 PM
Lexicon Pharmaceuticals (Issuer)
Tessmer James F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2020
3:11 PM
Lexicon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2019
11:15 PM
Lexicon Pharmaceuticals (Filer)
Form EFFECT
11/07/2019
3:32 PM
Lexicon Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/07/2019
3:22 PM
Lexicon Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/07/2019
3:06 PM
Lexicon Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2019
6:06 AM
Lexicon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2019
5:17 PM
Crum Brian T (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/19/2019
3:28 PM
COATS LONNEL (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2019
3:26 PM
Lexicon Pharmaceuticals (Issuer)
Santini Alexander A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2019
3:39 PM
COATS LONNEL (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2019
4:36 PM
DEBBANE RAYMOND (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2019
4:33 PM
DEBBANE RAYMOND (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2019
4:27 PM
Lexicon Pharmaceuticals (Issuer)
SOBECKI CHRISTOPHER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2019
4:23 PM
Lexicon Pharmaceuticals (Issuer)
SOBECKI CHRISTOPHER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2019
3:03 PM
Lexicon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2019
4:02 PM
COATS LONNEL (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2019
3:15 PM
Lexicon Pharmaceuticals (Issuer)
Tessmer James F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2019
3:12 PM
BARKER SAM L (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2019
3:53 PM
Lexicon Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/31/2019
6:11 AM
Lexicon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2019
6:17 AM
Lexicon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2019
4:08 PM
Lexicon Pharmaceuticals (Issuer)
Palantoni Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2019
4:07 PM
Amouyal Philippe (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2019
4:06 PM
Lexicon Pharmaceuticals (Issuer)
NIES ALAN S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2019
4:04 PM
DEBBANE RAYMOND (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2019
4:03 PM
Lexicon Pharmaceuticals (Issuer)
Swain Judith L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2019
4:02 PM
Lexicon Pharmaceuticals (Issuer)
SOBECKI CHRISTOPHER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2019
4:01 PM
BARKER SAM L (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2019
4:00 PM
LEFKOWITZ ROBERT J MD (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2019
1:50 PM
Lexicon Pharmaceuticals (Filer)
Form CT ORDER
03/13/2019
6:12 AM
Lexicon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/01/2019
4:20 PM
Lexicon Pharmaceuticals (Issuer)
WADE JEFFREY L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2019
4:19 PM
Lexicon Pharmaceuticals (Issuer)
TYLE PRAVEEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2019
4:18 PM
Lexicon Pharmaceuticals (Issuer)
Tessmer James F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2019
4:18 PM
Lexicon Pharmaceuticals (Issuer)
Santini Alexander A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2019
4:17 PM
Lexicon Pharmaceuticals (Issuer)
MAIN ALAN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2019
4:16 PM
Lapuerta Pablo (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2019
4:15 PM
COATS LONNEL (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2019
10:25 AM
Lexicon Pharmaceuticals (Subject)
UBS ASSET MANAGEMENT AMERICAS INC (Filed by)
Form SC 13G/A
02/08/2019
5:15 PM
Lexicon Pharmaceuticals (Issuer)
Tessmer James F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
5:13 PM
Lexicon Pharmaceuticals (Issuer)
TYLE PRAVEEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
5:10 PM
Lexicon Pharmaceuticals (Issuer)
Santini Alexander A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
5:07 PM
Lexicon Pharmaceuticals (Issuer)
MAIN ALAN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
5:05 PM
Lapuerta Pablo (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
5:02 PM
Lexicon Pharmaceuticals (Issuer)
WADE JEFFREY L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
4:59 PM
COATS LONNEL (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
4:52 PM
Lexicon Pharmaceuticals (Issuer)
WADE JEFFREY L (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
11/01/2018
4:17 PM
Lexicon Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/01/2018
6:14 AM
Lexicon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/04/2018
4:17 PM
Lexicon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2018
3:31 PM
Lexicon Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/30/2018
6:08 AM
Lexicon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/29/2018
3:09 PM
Invus, L.P. (Filed by)
Lexicon Pharmaceuticals (Subject)
Form SC 13D/A
06/26/2018
4:32 PM
Artal Group S.A. (Reporting)
Artal International Management S.A. (Reporting)
Artal International S.C.A. (Reporting)
Invus Advisors, L.L.C. (Reporting)
Invus Public Equities Advisors, LLC (Reporting)
Invus Public Equities, L.P. (Reporting)
Invus, L.P. (Reporting)
Lexicon Pharmaceuticals (Issuer)
Minne Pascal (Reporting)
Stichting Administratiekantoor Westend (Reporting)
Westend S.A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2018
4:55 PM
Artal Group S.A. (Reporting)
Artal International Management S.A. (Reporting)
Artal International S.C.A. (Reporting)
Invus Advisors, L.L.C. (Reporting)
Invus Public Equities Advisors, LLC (Reporting)
Invus Public Equities, L.P. (Reporting)
Invus, L.P. (Reporting)
Lexicon Pharmaceuticals (Issuer)
Minne Pascal (Reporting)
Stichting Administratiekantoor Westend (Reporting)
Westend S.A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2018
5:56 PM
Artal Group S.A. (Reporting)
Artal International Management S.A. (Reporting)
Artal International S.C.A. (Reporting)
Invus Advisors, L.L.C. (Reporting)
Invus Public Equities Advisors, LLC (Reporting)
Invus Public Equities, L.P. (Reporting)
Invus, L.P. (Reporting)
Lexicon Pharmaceuticals (Issuer)
Minne Pascal (Reporting)
Stichting Administratiekantoor Westend (Reporting)
Westend S.A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2018
5:10 PM
Artal Group S.A. (Reporting)
Artal International Management S.A. (Reporting)
Artal International S.C.A. (Reporting)
Invus Advisors, L.L.C. (Reporting)
Invus Public Equities Advisors, LLC (Reporting)
Invus Public Equities, L.P. (Reporting)
Invus, L.P. (Reporting)
Lexicon Pharmaceuticals (Issuer)
Minne Pascal (Reporting)
Stichting Administratiekantoor Westend (Reporting)
Westend S.A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2018
3:37 PM
Lexicon Pharmaceuticals (Issuer)
Tessmer James F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2018
6:37 PM
Artal Group S.A. (Reporting)
Artal International Management S.A. (Reporting)
Artal International S.C.A. (Reporting)
Invus Advisors, L.L.C. (Reporting)
Invus Public Equities Advisors, LLC (Reporting)
Invus Public Equities, L.P. (Reporting)
Invus, L.P. (Reporting)
Lexicon Pharmaceuticals (Issuer)
Minne Pascal (Reporting)
Stichting Administratiekantoor Westend (Reporting)
Westend S.A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2018
4:31 PM
Artal Group S.A. (Reporting)
Artal International Management S.A. (Reporting)
Artal International S.C.A. (Reporting)
Invus Advisors, L.L.C. (Reporting)
Invus Public Equities Advisors, LLC (Reporting)
Invus Public Equities, L.P. (Reporting)
Invus, L.P. (Reporting)
Lexicon Pharmaceuticals (Issuer)
Minne Pascal (Reporting)
Stichting Administratiekantoor Westend (Reporting)
Westend S.A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2018
5:31 AM
Invus, L.P. (Filed by)
Lexicon Pharmaceuticals (Subject)
Form SC 13D/A
05/30/2018
7:53 PM
Artal Group S.A. (Reporting)
Artal International Management S.A. (Reporting)
Artal International S.C.A. (Reporting)
Invus Advisors, L.L.C. (Reporting)
Invus Public Equities Advisors, LLC (Reporting)
Invus Public Equities, L.P. (Reporting)
Invus, L.P. (Reporting)
Lexicon Pharmaceuticals (Issuer)
Minne Pascal (Reporting)
Stichting Administratiekantoor Westend (Reporting)
Westend S.A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/25/2018
3:43 PM
Lexicon Pharmaceuticals (Issuer)
Santini Alexander A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2018
6:13 AM
Lexicon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/27/2018
4:42 PM
Lexicon Pharmaceuticals (Issuer)
Swain Judith L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2018
4:41 PM
Lexicon Pharmaceuticals (Issuer)
SOBECKI CHRISTOPHER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2018
4:40 PM
Lexicon Pharmaceuticals (Issuer)
Palantoni Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2018
4:39 PM
Lexicon Pharmaceuticals (Issuer)
NIES ALAN S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2018
4:38 PM
LEFKOWITZ ROBERT J MD (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2018
4:37 PM
DEBBANE RAYMOND (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2018
4:36 PM
BARKER SAM L (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2018
4:35 PM
Amouyal Philippe (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/26/2018
3:56 PM
Lexicon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2018
4:16 PM
Lexicon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/16/2018
6:10 AM
Lexicon Pharmaceuticals (Filer)
Form DEFA14A
03/16/2018
6:06 AM
Lexicon Pharmaceuticals (Filer)
Form DEF 14A
03/02/2018
4:12 PM
Lexicon Pharmaceuticals (Issuer)
WADE JEFFREY L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2018
4:11 PM
Lexicon Pharmaceuticals (Issuer)
TYLE PRAVEEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2018
4:11 PM
Lexicon Pharmaceuticals (Issuer)
Tessmer James F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2018
4:09 PM
Lexicon Pharmaceuticals (Issuer)
Santini Alexander A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2018
4:08 PM
Lexicon Pharmaceuticals (Issuer)
MAIN ALAN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2018
4:08 PM
Lapuerta Pablo (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2018
4:07 PM
COATS LONNEL (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2018
6:07 AM
Lexicon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2018
3:18 PM
Lexicon Pharmaceuticals (Subject)
UBS ASSET MANAGEMENT AMERICAS INC (Filed by)
Form SC 13G/A
02/12/2018
4:18 PM
Lexicon Pharmaceuticals (Issuer)
WADE JEFFREY L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2018
4:17 PM
Lexicon Pharmaceuticals (Issuer)
TYLE PRAVEEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2018
4:15 PM
Lexicon Pharmaceuticals (Issuer)
Tessmer James F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 7/12/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.